Por: MarketWatch Business January 03, 2023
The XBB.1.5 subvariant has spread quickly. It accounted for just 1.3% of new cases in the first week of December and has more than doubled its share every week since then. In the New York region, which includes New Jersey, Puerto Rico and the U.S. Virgin Islands, it accounted for 72.2% of new cases in the latest week. While the subvariant appears more infectious than earlier ones, data do not suggest it’s more risky. But experts are urging... + full article
The Hill USA Politics January 04, 2023
White House health officials are cautioning against a rush to panic over the XBB.1.5 omicron subvariant, which has rapidly grown to account for 40 percent of U.S. COVID-19 cases, with officials stating it is not yet known if this version is more dangerous. As of last week, the... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Omicron XBB.1.5 Is Rising in U.S. Though Revised CDC Data Shows Slower Increase Than Previously Reported | NBC 6 South Florida
NBC News USA Science December 31, 2022
A new version of omicron has taken hold in the U.S., according to the most recent data from the Centers for Disease Control and Prevention. The subvariant of omicron, named XBB.1.5, has raised concerns about another potential wave of Covid cases following the busy holiday travel... + más
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
CNBC USA Health December 07, 2022
A staff member draws up a syringe with the Comirnaty vaccine from Biontech and Pfizer adapted to the Omicron-BA.1 variant at the Mainz vaccination center.Sebastian Christoph Gollnow dpa Picture Alliance Getty ImagesCovid shots designed to protect against the omicron variant... + más
Omicron Boosters Are Weaker Against BQ.1.1 Subvariant That Is Rising in U.S., Study Finds | NBC 6 South Florida
Moderna says new Covid booster better against omicron BA.5, triggers immune response against BQ.1.1 | CNBC
NBC 6 South Florida USA World December 06, 2022
Sebastian Christoph Gollnow dpa Picture Alliance Getty Images A staff member draws up a syringe with the Comirnaty vaccine from Biontech and Pfizer adapted to the Omicron-BA.1 variant at the Mainz vaccination center. data-ellipsis=false> Covid shots designed to protect against... + más
Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds | CNBC
The Boston Globe USA Nation November 18, 2022
WASHINGTON — A new study by Moderna suggests that its updated coronavirus booster strengthens a key component of the immune system’s defense against the omicron subvariant that accounted for most infections in the United States in recent months.The company announced the... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna says updated booster stronger against omicron subvariants | ABC7
CNBC USA Health November 14, 2022
In this articleA vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, September 8, 2022.Hannah Beier ReutersModerna's new Covid booster triggered a... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
CNBC USA Health October 13, 2022
In this articleJakub Porzycki NurPhoto Getty Images and its German partner on Thursday said their new omicron boosters substantially increased protective antibodies against the dominant omicron BA.5 subvariant for adults in the first direct human data released to the public on... + más
Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11 | CNBC
The New Bivalent Booster Increases Antibodies to Fight Omicron, Data Show | Time
About iurex | Privacy Policy | Disclaimer |